Therapeutic Options to Treat Autoimmune Hepatitis in 2009

被引:5
作者
Strassburg, Christian P. [1 ]
机构
[1] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, DE-30625 Hannover, Germany
关键词
Immunosuppression; Autoimmune hepatitis; Steroids; Budesonide; Azathioprine; Remission; LIVER-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; AZATHIOPRINE; MAINTENANCE; REMISSION; SURVIVAL;
D O I
10.1159/000282071
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
First described in 1950, autoimmune hepatitis (AIH) was the first chronic liver disease with a favorable response to drug therapy and a dismal prognosis when left untreated. In the decades since the first treatment studies, the basic strategy of inducing remission with steroids and azathioprine have not been modified in principle. The main problems are a timely diagnosis before cirrhosis develops, the avoidance of immunosuppressant side effects, nonresponders to standard induction therapy and adherence to therapy. Alternative drugs for immunosuppression have been tested in small series and include transplant immunosuppressants. A large multicenter prospective treatment trial suggests that budesonide may offer an alternative in noncirrhotic AIH patients, capable of minimizing unwanted steroid effects. The ultimate treatment approach is liver transplantation. Although only 4% of transplant patients are transplanted with the diagnosis AIH, the risk for graft loss because of recurrence has to be considered and recurrent AIH treated after transplantation. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:93 / 98
页数:6
相关论文
共 16 条
[1]   International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis [J].
Alvarez, E ;
Berg, PA ;
Bianchi, FB ;
Bianchi, L ;
Burroughs, AK ;
Cancado, EL ;
Chapman, RW ;
Cooksley, WGE ;
Czaja, AJ ;
Desmet, VJ ;
Donaldson, RT ;
Eddleston, ALWF ;
Fainboim, L ;
Heathcote, J ;
Homberg, JC ;
Hoofnagle, JH ;
Kakumu, S ;
Krawitt, EL ;
Mackay, IR ;
MacSween, RNM ;
Maddrey, WC ;
Manns, MP ;
McFarlane, IG ;
zum Büschenfelde, KHM ;
Mieli-Vergani, G ;
Nakanuma, Y ;
Nishioka, M ;
Penner, E ;
Porta, G ;
Portmann, BC ;
Reed, WD ;
Rodes, J ;
Schalm, SW ;
Scheuer, PJ ;
Schrumpf, E ;
Seki, T ;
Toda, G ;
Tsuji, T ;
Tygstrup, N ;
Vergani, D ;
Zeniya, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (05) :929-938
[2]   Mycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis? [J].
Hennes, Elke M. ;
Oo, Ye H. ;
Schramm, Christoph ;
Denzer, Ulrike ;
Buggisch, Peter ;
Wiegard, Christiane ;
Kanzler, Stephan ;
Schuchmann, Marcus ;
Boecher, Wulf ;
Galle, Peter R. ;
Adams, David H. ;
Lohse, Ansgar W. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (12) :3063-3070
[3]   AZATHIOPRINE FOR LONG-TERM MAINTENANCE OF REMISSION IN AUTOIMMUNE HEPATITIS [J].
JOHNSON, PJ ;
MCFARLANE, IG ;
WILLIAMS, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (15) :958-963
[4]   LATE RESULTS OF THE ROYAL-FREE-HOSPITAL PROSPECTIVE CONTROLLED TRIAL OF PREDNISOLONE THERAPY IN HEPATITIS-B SURFACE-ANTIGEN NEGATIVE CHRONIC ACTIVE HEPATITIS [J].
KIRK, AP ;
JAIN, S ;
POCOCK, S ;
THOMAS, HC ;
SHERLOCK, S .
GUT, 1980, 21 (01) :78-83
[5]   Autoimmune hepatitis: Clinical challenges [J].
Manns, MP ;
Strassburg, CP .
GASTROENTEROLOGY, 2001, 120 (06) :1502-1517
[6]   Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine [J].
Richardson, PD ;
James, PD ;
Ryder, SD .
JOURNAL OF HEPATOLOGY, 2000, 33 (03) :371-375
[7]   The impact of disease recurrence on graft survival following liver transplantation: a single centre experience [J].
Rowe, Ian A. ;
Webb, Kerry ;
Gunson, Bridget K. ;
Mehta, Naimish ;
Haque, Sayeed ;
Neuberger, James .
TRANSPLANT INTERNATIONAL, 2008, 21 (05) :459-465
[8]   Progress in immunosuppression [J].
Strassburg, C. P. ;
Bahr, M. J. ;
Becker, T. ;
Klempnauer, J. ;
Manns, M. P. .
CHIRURG, 2008, 79 (02) :149-156
[9]  
Strassburg CP, 2009, INTERNIST, V50, P1358, DOI 10.1007/s00108-009-2464-1
[10]   Liver transplantation: indications and results [J].
Strassburg, C. P. ;
Manns, M. P. .
INTERNIST, 2009, 50 (05) :550-560